Delivery Order SPE2DB22D2005-SPE2DB25FJLC5

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,735.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,397,986 units of Ondansetron ODT 4 mg tablets, with a completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This is a $6,028.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,617,751 units of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. The award has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,570.36 fixed-price delivery order is for the supply of 4,567,892,281 units of Ondansetron ODT 4 mg tablets, with a period of performance through April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,536.12, is for the delivery of 4,568,235,550 units of Ondansetron ODT 8 mg tablets in a 30-count package. The award has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any particular...
This is a $14,899.20 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a $11,793.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,256,298 units of Ondansetron HCL 4 mg tablets. The order has a completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,214,940 units of the drug ondansetron ODT 4 mg tablet. The delivery order, valued at $1,883.31, is a firm-fixed-price contract with a completion date of July 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support...
This is a $9,431.17 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for 4,561,622,719 units of Ondansetron ODT 4 mg Tablets, with a period of performance ending on July 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $10,367.97 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for 4,564,591,691 units of the medication Ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of May 14, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides medical products to federal government agencies, particularly within military and veterans' healthcare systems. This delivery order is part of a larger...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,850.36 firm fixed-price delivery order is for 4,566,178,476 units of the generic drug Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of October 23, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJLC5
    Delivery Order

This is a $2,576.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,908,335 units of the drug Ondansetron ODT 8 mg tablet, with a period of performance through April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award does not have a set-aside designation, indicating open competition. The contract aligns with DLA's role in supplying medical products to federal government agencies, particularly military and veterans' healthcare systems.

Generated 7/14/25, 10:49 AM